Last 12 months
Inside the activity.
3 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 3 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 12, 2019 Filed Feb 14, 2019 19:27 UTC |
Fenton AndrewExecutive Vice President
|
GrantPerformance Award Unit · Derivative | 6,442.0896 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-19-000064 · wf-form4_155019043148491.xml · derivative · entry 3 Fenton Andrew · CIK 0001538226 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,442.0896 Underlying: Common Stock · 6,442.0896 shares Expires not disclosed F10 · security: Represents performance award units with a three-year performance period covering 2016-2018 that were granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 12, 2019, which is the date the Zoetis Compensation Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) will vest and be settled in shares of Zoetis common stock on February 19, 2019, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F11 · derivative.exercise_price: Each performance award unit represents a contingent right to receive one share of Zoetis Inc. common stock. F12 · derivative.exercise_date: Each performance award unit will vest and be settled in shares of Zoetis Inc. common stock on February 19, 2019, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 19:27 UTC |
Fenton AndrewExecutive Vice President
|
GrantStock Option · Derivative | 13,774 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-19-000064 · wf-form4_155019043148491.xml · derivative · entry 2 Fenton Andrew · CIK 0001538226 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,251 Underlying: Common Stock · 13,774 shares Expires not disclosed F6 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F7 · derivative.exercise_price: 12,853 options granted February 27, 2015 at an exercise price of $46.09 per option; 14,149 options granted February 19, 2016 at an exercise price of $41.83 per option; 3,872 options granted August 22, 2016 at an exercise price of $51.32 per option; 11,144 options granted December 6, 2016 at an exercise price of $50.22 per option; 16,317 options granted February 14, 2017 at an exercise price of $55.02 per option; 13,142 options granted February 13, 2018 at an exercise price of $73.24 per option; and 13,774 options granted February 12, 2019 at an exercise price of $87.51. F8 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F9 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F7 · balance_after: 12,853 options granted February 27, 2015 at an exercise price of $46.09 per option; 14,149 options granted February 19, 2016 at an exercise price of $41.83 per option; 3,872 options granted August 22, 2016 at an exercise price of $51.32 per option; 11,144 options granted December 6, 2016 at an exercise price of $50.22 per option; 16,317 options granted February 14, 2017 at an exercise price of $55.02 per option; 13,142 options granted February 13, 2018 at an exercise price of $73.24 per option; and 13,774 options granted February 12, 2019 at an exercise price of $87.51. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 19:27 UTC |
Fenton AndrewExecutive Vice President
|
GrantRestricted Stock Unit · Derivative | 3,428 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-19-000064 · wf-form4_155019043148491.xml · derivative · entry 1 Fenton Andrew · CIK 0001538226 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,275.7112 Underlying: Common Stock · 3,428 shares Expires not disclosed F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. F5 · balance_after: The RSUs vest as follows: 3,865.4580 RSUs will vest on February 19, 2019; 991.7401 RSUs will vest on August 22, 2019; 3,031.3841 RSUs will vest on December 6, 2019; 4,296.0854 RSUs will vest on February 14, 2020; 3,663.0436 RSUs will vest on February 13, 2021; and 3,428.0000 RSUs will vest on February 12, 2022. Read SEC document |
| February 12, 2019 Filed Feb 15, 2019 00:37 UTC |
Trawicki RomanExecutive Vice President
|
GrantPerformance Award Unit · Derivative | 8,137.376 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-19-000069 · wf-form4_155019100811338.xml · derivative · entry 3 Trawicki Roman · CIK 0001640777 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,137.376 Underlying: Common Stock · 8,137.376 shares Expires not disclosed F10 · security: Represents performance award units with a three-year performance period covering 2016-2018 that were granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 12, 2019, which is the date the Zoetis Compensation Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) will vest and be settled in shares of Zoetis common stock on February 19, 2019, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F11 · derivative.exercise_price: Each performance award unit represents a contingent right to receive one share of Zoetis Inc. common stock. F12 · derivative.exercise_date: Each performance award unit will vest and be settled in shares of Zoetis Inc. common stock on February 19, 2019, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. Read SEC document |
| February 12, 2019 Filed Feb 15, 2019 00:37 UTC |
Trawicki RomanExecutive Vice President
|
GrantStock Option · Derivative | 13,774 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-19-000069 · wf-form4_155019100811338.xml · derivative · entry 2 Trawicki Roman · CIK 0001640777 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,106 Underlying: Common Stock · 13,774 shares Expires not disclosed F6 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F7 · derivative.exercise_price: 17,873 options granted February 19, 2016 at an exercise price of $41.83 per option; 16,317 options granted February 14, 2017 at an exercise price of $55.02 per option; 13,142 options granted February 13, 2018 at an exercise price of $73.24 per option; and 13,774 options granted February 12, 2019 at an exercise price of $87.51. F8 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F9 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F7 · balance_after: 17,873 options granted February 19, 2016 at an exercise price of $41.83 per option; 16,317 options granted February 14, 2017 at an exercise price of $55.02 per option; 13,142 options granted February 13, 2018 at an exercise price of $73.24 per option; and 13,774 options granted February 12, 2019 at an exercise price of $87.51. Read SEC document |
| February 12, 2019 Filed Feb 15, 2019 00:37 UTC |
Trawicki RomanExecutive Vice President
|
GrantRestricted Stock Unit · Derivative | 3,428 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-19-000069 · wf-form4_155019100811338.xml · derivative · entry 1 Trawicki Roman · CIK 0001640777 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,269.7591 Underlying: Common Stock · 3,428 shares Expires not disclosed F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. F5 · balance_after: The RSUs vest as follows: 4,882.6301 RSUs will vest on February 19, 2019; 4,296.0854 RSUs will vest on February 14, 2020; 3,663.0436 RSUs will vest on February 13, 2021; and 3,428.0000 RSUs will vest on February 12, 2022. Read SEC document |
| February 12, 2019 Filed Feb 15, 2019 00:32 UTC |
Lewis Clinton A. Jr.Executive Vice President
|
GrantPerformance Award Unit · Derivative | 16,274.7526 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-19-000067 · wf-form4_155019076195107.xml · derivative · entry 3 Lewis Clinton A. Jr. · CIK 0001567831 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,274.7526 Underlying: Common Stock · 16,274.7526 shares Expires not disclosed F10 · security: Represents performance award units with a three-year performance period covering 2016-2018 that were granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 12, 2019, which is the date the Zoetis Compensation Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) will vest and be settled in shares of Zoetis common stock on February 19, 2019, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F11 · derivative.exercise_price: Each performance award unit represents a contingent right to receive one share of Zoetis Inc. common stock. F12 · derivative.exercise_date: Each performance award unit will vest and be settled in shares of Zoetis Inc. common stock on February 19, 2019, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. Read SEC document |
| February 12, 2019 Filed Feb 15, 2019 00:32 UTC |
Lewis Clinton A. Jr.Executive Vice President
|
GrantStock Option · Derivative | 20,661 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-19-000067 · wf-form4_155019076195107.xml · derivative · entry 2 Lewis Clinton A. Jr. · CIK 0001567831 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 228,291 Underlying: Common Stock · 20,661 shares Expires not disclosed F6 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. Each option vests on the third anniversary of the date of grant. F7 · derivative.exercise_price: 39,229 options granted January 31, 2013 at an exercise price of $26.00 per option; 46,816 options granted March 4, 2014 at an exercise price of $30.89 per option; 28,563 options granted February 27, 2015 at an exercise price of $46.09 per option; 35,746 options granted February 19, 2016 at an exercise price of $41.83 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; 24,642 options granted February 13, 2018 at an exercise price of $73.24 per option; and 20,661 options granted February 12, 2019 at an exercise price of $87.51. F8 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F9 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F7 · balance_after: 39,229 options granted January 31, 2013 at an exercise price of $26.00 per option; 46,816 options granted March 4, 2014 at an exercise price of $30.89 per option; 28,563 options granted February 27, 2015 at an exercise price of $46.09 per option; 35,746 options granted February 19, 2016 at an exercise price of $41.83 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; 24,642 options granted February 13, 2018 at an exercise price of $73.24 per option; and 20,661 options granted February 12, 2019 at an exercise price of $87.51. Read SEC document |
| February 12, 2019 Filed Feb 15, 2019 00:32 UTC |
Lewis Clinton A. Jr.Executive Vice President
|
GrantRestricted Stock Unit · Derivative | 5,142 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-19-000067 · wf-form4_155019076195107.xml · derivative · entry 1 Lewis Clinton A. Jr. · CIK 0001567831 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,369.6572 Underlying: Common Stock · 5,142 shares Expires not disclosed F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. F5 · balance_after: The RSUs vest as follows: 9,765.2597 RSUs will vest on February 19, 2019; 8,593.1842 RSUs will vest on February 14, 2020; 6,869.2133 RSUs will vest on February 13, 2021; and 5,142.0000 RSUs will vest on February 12, 2022. Read SEC document |
| February 12, 2019 Filed Feb 15, 2019 00:31 UTC |
Lagano RoxanneExecutive Vice President
|
GrantPerformance Award Unit · Derivative | 8,815.4908 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-19-000066 · wf-form4_155019066403826.xml · derivative · entry 3 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,815.4908 Underlying: Common Stock · 8,815.4908 shares Expires not disclosed F10 · security: Represents performance award units with a three-year performance period covering 2016-2018 that were granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 12, 2019, which is the date the Zoetis Compensation Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) will vest and be settled in shares of Zoetis common stock on February 19, 2019, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F11 · derivative.exercise_price: Each performance award unit represents a contingent right to receive one share of Zoetis Inc. common stock. F12 · derivative.exercise_date: Each performance award unit will vest and be settled in shares of Zoetis Inc. common stock on February 19, 2019, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. Read SEC document |
| February 12, 2019 Filed Feb 15, 2019 00:31 UTC |
Lagano RoxanneExecutive Vice President
|
GrantStock Option · Derivative | 12,052 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-19-000066 · wf-form4_155019066403826.xml · derivative · entry 2 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,165 Underlying: Common Stock · 12,052 shares Expires not disclosed F6 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F7 · derivative.exercise_price: 31,453 options granted March 4, 2014 at an exercise price of $30.89 per option; 17,852 options granted February 27, 2015 at an exercise price of $46.09 per option; 19,362 options granted February 19, 2016 at an exercise price of $41.83 per option; 17,482 options granted February 14, 2017 at an exercise price of $55.02 per option; 13,964 options granted February 13, 2018 at an exercise price of $73.24 per option; and 12,052 options granted February 12, 2019 at an exercise price of $87.51. F8 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F9 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F7 · balance_after: 31,453 options granted March 4, 2014 at an exercise price of $30.89 per option; 17,852 options granted February 27, 2015 at an exercise price of $46.09 per option; 19,362 options granted February 19, 2016 at an exercise price of $41.83 per option; 17,482 options granted February 14, 2017 at an exercise price of $55.02 per option; 13,964 options granted February 13, 2018 at an exercise price of $73.24 per option; and 12,052 options granted February 12, 2019 at an exercise price of $87.51. Read SEC document |
| February 12, 2019 Filed Feb 15, 2019 00:31 UTC |
Lagano RoxanneExecutive Vice President
|
GrantRestricted Stock Unit · Derivative | 2,999 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-19-000066 · wf-form4_155019066403826.xml · derivative · entry 1 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,783.6708 Underlying: Common Stock · 2,999 shares Expires not disclosed F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. F5 · balance_after: The RSUs vest as follows: 5,289.0903 RSUs will vest on February 19, 2019; 4,603.0934 RSUs will vest on February 14, 2020; 3,892.4871 RSUs will vest on February 13, 2021; and 2,999.0000 RSUs will vest on February 12, 2022. Read SEC document |
| February 12, 2019 Filed Feb 15, 2019 00:29 UTC |
Knupp Catherine A.Executive Vice President
|
GrantPerformance Award Unit · Derivative | 14,918.523 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-19-000065 · wf-form4_155019054771426.xml · derivative · entry 3 Knupp Catherine A. · CIK 0001567826 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,918.523 Underlying: Common Stock · 14,918.523 shares Expires not disclosed F10 · security: Represents performance award units with a three-year performance period covering 2016-2018 that were granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 12, 2019, which is the date the Zoetis Compensation Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) will vest and be settled in shares of Zoetis common stock on February 19, 2019, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F11 · derivative.exercise_price: Each performance award unit represents a contingent right to receive one share of Zoetis Inc. common stock. F12 · derivative.exercise_date: Each performance award unit will vest and be settled in shares of Zoetis Inc. common stock on February 19, 2019, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. Read SEC document |
| February 12, 2019 Filed Feb 15, 2019 00:29 UTC |
Knupp Catherine A.Executive Vice President
|
GrantStock Option · Derivative | 20,661 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-19-000065 · wf-form4_155019054771426.xml · derivative · entry 2 Knupp Catherine A. · CIK 0001567826 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,267 Underlying: Common Stock · 20,661 shares Expires not disclosed F6 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F7 · derivative.exercise_price: 28,563 options granted February 27, 2015 at an exercise price of $46.09 per option; 32,767 options granted February 19, 2016 at an exercise price of $41.83 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; 24,642 options granted February 13, 2018 at an exercise price of $73.24 per option; and 20,661 options granted February 12, 2019 at an exercise price of $87.51. F8 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F9 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F7 · balance_after: 28,563 options granted February 27, 2015 at an exercise price of $46.09 per option; 32,767 options granted February 19, 2016 at an exercise price of $41.83 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; 24,642 options granted February 13, 2018 at an exercise price of $73.24 per option; and 20,661 options granted February 12, 2019 at an exercise price of $87.51. Read SEC document |
| February 12, 2019 Filed Feb 15, 2019 00:29 UTC |
Knupp Catherine A.Executive Vice President
|
GrantRestricted Stock Unit · Derivative | 5,142 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-19-000065 · wf-form4_155019054771426.xml · derivative · entry 1 Knupp Catherine A. · CIK 0001567826 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,555.7157 Underlying: Common Stock · 5,142 shares Expires not disclosed F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. F5 · balance_after: The RSUs vest as follows: 8,951.3182 RSUs will vest on February 19, 2019; 8,593.1842 RSUs will vest on February 14, 2020; 6,869.2133 RSUs will vest on February 13, 2021; and 5,142.0000 RSUs will vest on February 12, 2022. Read SEC document |
| February 12, 2019 Filed Feb 15, 2019 00:23 UTC |
Chen Heidi C.Executive Vice President
|
GrantPerformance Award Unit · Derivative | 12,884.1794 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-19-000062 · wf-form4_155019021163581.xml · derivative · entry 3 Chen Heidi C. · CIK 0001567828 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,884.1794 Underlying: Common Stock · 12,884.1794 shares Expires not disclosed F10 · security: Represents performance award units with a three-year performance period covering 2016-2018 that were granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 12, 2019, which is the date the Zoetis Compensation Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) will vest and be settled in shares of Zoetis common stock on February 19, 2019, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F11 · derivative.exercise_price: Each performance award unit represents a contingent right to receive one share of Zoetis Inc. common stock. F12 · derivative.exercise_date: Each performance award unit will vest and be settled in shares of Zoetis Inc. common stock on February 19, 2019, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. Read SEC document |
| February 12, 2019 Filed Feb 15, 2019 00:23 UTC |
Chen Heidi C.Executive Vice President
|
GrantStock Option · Derivative | 14,921 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-19-000062 · wf-form4_155019021163581.xml · derivative · entry 2 Chen Heidi C. · CIK 0001567828 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,437 Underlying: Common Stock · 14,921 shares Expires not disclosed F6 · security: Stock option (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The option vests on the third anniversary of the date of grant. F7 · derivative.exercise_price: 22,850 options granted February 27, 2015 at an exercise price of $46.09 per option; 28,299 options granted February 19, 2016 at an exercise price of $41.83 per option; 24,475 options granted February 14, 2017 at an exercise price of $55.02 per option; 18,892 options granted February 13, 2018 at an exercise price of $73.24 per option; and 14,921 options granted February 12, 2019 at an exercise price of $87.51. F8 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F9 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F7 · balance_after: 22,850 options granted February 27, 2015 at an exercise price of $46.09 per option; 28,299 options granted February 19, 2016 at an exercise price of $41.83 per option; 24,475 options granted February 14, 2017 at an exercise price of $55.02 per option; 18,892 options granted February 13, 2018 at an exercise price of $73.24 per option; and 14,921 options granted February 12, 2019 at an exercise price of $87.51. Read SEC document |
| February 12, 2019 Filed Feb 15, 2019 00:23 UTC |
Chen Heidi C.Executive Vice President
|
GrantRestricted Stock Unit · Derivative | 3,713 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-19-000062 · wf-form4_155019021163581.xml · derivative · entry 1 Chen Heidi C. · CIK 0001567828 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,155.1859 Underlying: Common Stock · 3,713 shares Expires not disclosed F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. F5 · balance_after: The RSUs vest as follows: 7,730.9161 RSUs will vest on February 19, 2019; 6,445.1413 RSUs will vest on February 14, 2020; 5,266.1285 RSUs will vest on February 13, 2021; and 3,713.0000 RSUs will vest on February 12, 2022. Read SEC document |
| February 12, 2019 Filed Feb 15, 2019 00:22 UTC |
Alaix Juan RamonDirector · Chief Executive Officer
|
GrantPerformance Award Unit · Derivative | 85,442.4512 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-19-000061 · wf-form4_155019012085567.xml · derivative · entry 3 Alaix Juan Ramon · CIK 0001567824 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,442.4512 Underlying: Common Stock · 85,442.4512 shares Expires not disclosed F10 · security: Represents performance award units with a three-year performance period covering 2016-2018 that were granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 12, 2019, which is the date the Zoetis Compensation Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) will vest and be settled in shares of Zoetis common stock on February 19, 2019, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F11 · derivative.exercise_price: Each performance award unit represents a contingent right to receive one share of Zoetis Inc. common stock. F12 · derivative.exercise_date: Each performance award unit will vest and be settled in shares of Zoetis Inc. common stock on February 19, 2019, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. Read SEC document |
| February 12, 2019 Filed Feb 15, 2019 00:22 UTC |
Alaix Juan RamonDirector · Chief Executive Officer
|
GrantStock Option · Derivative | 110,192 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-19-000061 · wf-form4_155019012085567.xml · derivative · entry 2 Alaix Juan Ramon · CIK 0001567824 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,073,155 Underlying: Common Stock · 110,192 shares Expires not disclosed F6 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F7 · derivative.exercise_price: 312,109 options granted March 4, 2014 at an exercise price of $30.89 per option; 159,954 options granted February 27, 2015 at an exercise price of $46.09 per option; 187,667 options granted February 19, 2016 at an exercise price of $41.83 per option; 170,163 options granted February 14, 2017 at an exercise price of $55.02 per option; 133,070 options granted February 13, 2018 at an exercise price of $73.24 per option; and 110,192 options granted February 12, 2019 at an exercise price of $87.51. F8 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F9 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F7 · balance_after: 312,109 options granted March 4, 2014 at an exercise price of $30.89 per option; 159,954 options granted February 27, 2015 at an exercise price of $46.09 per option; 187,667 options granted February 19, 2016 at an exercise price of $41.83 per option; 170,163 options granted February 14, 2017 at an exercise price of $55.02 per option; 133,070 options granted February 13, 2018 at an exercise price of $73.24 per option; and 110,192 options granted February 12, 2019 at an exercise price of $87.51. Read SEC document |
| February 12, 2019 Filed Feb 15, 2019 00:22 UTC |
Alaix Juan RamonDirector · Chief Executive Officer
|
GrantRestricted Stock Unit · Derivative | 27,425 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-19-000061 · wf-form4_155019012085567.xml · derivative · entry 1 Alaix Juan Ramon · CIK 0001567824 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,604.5574 Underlying: Common Stock · 27,425 shares Expires not disclosed F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. F4 · derivative.expiration_date: Not applicable. F5 · balance_after: The RSUs vest as follows: 51,270.1685 RSUs will vest on February 19, 2019; 44,811.0081 RSUs will vest on February 14, 2020; 37,098.3808 RSUs will vest on February 13, 2021; and 27,425.0000 RSUs will vest on February 12, 2022. Read SEC document |
| January 14, 2019 Filed Jan 16, 2019 21:20 UTC |
Lewis Clinton A. Jr.Executive Vice President
|
Exercise / conversionStock Option · Derivative | 3,567 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-19-000020 · wf-form4_154767363241763.xml · derivative · entry 3 Lewis Clinton A. Jr. · CIK 0001567831 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 207,630 Underlying: Common Stock · 3,567 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. Each option vests on the third anniversary of the date of grant. F3 · derivative.exercise_price: 3,567 options granted January 31, 2013 at an exercise price of $26.00 per option. F4 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F5 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F6 · balance_after: 39,229 options granted January 31, 2013 at an exercise price of $26.00 per option; 46,816 options granted March 4, 2014 at an exercise price of $30.89 per option; 28,563 options granted February 27, 2015 at an exercise price of $46.09 per option; 35,746 options granted February 19, 2016 at an exercise price of $41.83 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; and 24,642 options granted February 13, 2018 at an exercise price of $73.24 per option. Read SEC document |
| January 14, 2019 Filed Jan 16, 2019 21:20 UTC |
Lewis Clinton A. Jr.Executive Vice President
|
SaleCommon Stock | 6,125 | $85.21 | $521,911.25 |
DisclosureSEC source: 0001555280-19-000020 · wf-form4_154767363241763.xml · nonDerivative · entry 2 Lewis Clinton A. Jr. · CIK 0001567831 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,945 F1 · price: The Price reported in Table I, Column 4 is the price at which these shares were sold in multiple transactions. Read SEC document |
| January 14, 2019 Filed Jan 16, 2019 21:20 UTC |
Lewis Clinton A. Jr.Executive Vice President
|
Exercise / conversionCommon Stock | 3,567 | $26.00 | $92,742.00 |
DisclosureSEC source: 0001555280-19-000020 · wf-form4_154767363241763.xml · nonDerivative · entry 1 Lewis Clinton A. Jr. · CIK 0001567831 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,070 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 11, 2019 Filed Jan 15, 2019 21:59 UTC |
PECK KRISTIN CExecutive Vice President
|
GrantPhantom Stock Unit · Derivative | 333.4517 | $27.25 | $9,086.56 |
DisclosureSEC source: 0001555280-19-000017 · wf-form4_154758955571458.xml · derivative · entry 1 PECK KRISTIN C · CIK 0001488267 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,090.5834 Underlying: Common Stock · 105.584 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| January 11, 2019 Filed Jan 15, 2019 16:28 UTC |
Fenton AndrewExecutive Vice President
|
GrantPhantom Stock Unit · Derivative | 299.7523 | $27.25 | $8,168.25 |
DisclosureSEC source: 0001555280-19-000011 · wf-form4_154758767287568.xml · derivative · entry 1 Fenton Andrew · CIK 0001538226 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,396.5934 Underlying: Common Stock · 94.9134 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| January 11, 2019 Filed Jan 15, 2019 22:04 UTC |
David GlennChief Financial Officer
|
GrantPhantom Stock Unit · Derivative | 309.3692 | $27.25 | $8,430.31 |
DisclosureSEC source: 0001555280-19-000018 · wf-form4_154758982452695.xml · derivative · entry 1 David Glenn · CIK 0001606256 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,599.9097 Underlying: Common Stock · 97.9585 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| January 11, 2019 Filed Jan 15, 2019 21:55 UTC |
Lagano RoxanneExecutive Vice President
|
GrantPhantom Stock Unit · Derivative | 244.5299 | $27.25 | $6,663.44 |
DisclosureSEC source: 0001555280-19-000016 · wf-form4_154758932880066.xml · derivative · entry 1 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,574.0446 Underlying: Common Stock · 77.4278 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| January 11, 2019 Filed Jan 15, 2019 21:51 UTC |
Alaix Juan RamonDirector · Chief Executive Officer
|
GrantPhantom Stock Unit · Derivative | 592.8011 | $27.25 | $16,153.83 |
DisclosureSEC source: 0001555280-19-000015 · wf-form4_154758905622095.xml · derivative · entry 1 Alaix Juan Ramon · CIK 0001567824 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,153.7358 Underlying: Common Stock · 187.7043 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| January 11, 2019 Filed Jan 15, 2019 21:46 UTC |
Knupp Catherine A.Executive Vice President
|
GrantPhantom Stock Unit · Derivative | 309.3692 | $27.25 | $8,430.31 |
DisclosureSEC source: 0001555280-19-000014 · wf-form4_154758878965248.xml · derivative · entry 1 Knupp Catherine A. · CIK 0001567826 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,888.4427 Underlying: Common Stock · 97.9585 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| January 11, 2019 Filed Jan 15, 2019 21:39 UTC |
Lewis Clinton A. Jr.Executive Vice President
|
GrantPhantom Stock Unit · Derivative | 333.4517 | $27.25 | $9,086.56 |
DisclosureSEC source: 0001555280-19-000013 · wf-form4_154758834683881.xml · derivative · entry 1 Lewis Clinton A. Jr. · CIK 0001567831 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,465.7652 Underlying: Common Stock · 105.584 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| January 11, 2019 Filed Jan 15, 2019 21:32 UTC |
Chen Heidi C.Executive Vice President
|
GrantPhantom Stock Unit · Derivative | 268.6125 | $27.25 | $7,319.69 |
DisclosureSEC source: 0001555280-19-000012 · wf-form4_154758796086806.xml · derivative · entry 1 Chen Heidi C. · CIK 0001567828 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 268.6125 Underlying: Common Stock · 85.0533 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| December 31, 2018 Filed Jan 2, 2019 21:19 UTC |
Lagano RoxanneExecutive Vice President
|
Exercise / conversionStock Option · Derivative | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-19-000002 · wf-form4_154646395153651.xml · derivative · entry 3 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,113 Underlying: Common Stock · 2,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F3 · derivative.exercise_price: 2,000 options granted March 4, 2014 at an exercise price of $30.89 per option. F4 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F5 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F6 · balance_after: 31,453 options granted March 4, 2014 at an exercise price of $30.89 per option; 17,852 options granted February 27, 2015 at an exercise price of $46.09 per option; 19,362 options granted February 19, 2016 at an exercise price of $41.83 per option; 17,482 options granted February 14, 2017 at an exercise price of $55.02 per option; and 13,964 options granted February 13, 2018 at an exercise price of $73.24 per option. Read SEC document |
| December 31, 2018 Filed Jan 2, 2019 21:19 UTC |
Lagano RoxanneExecutive Vice President
|
SaleCommon Stock | 2,000 | $85.30 | $170,600.00 |
DisclosureSEC source: 0001555280-19-000002 · wf-form4_154646395153651.xml · nonDerivative · entry 2 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,023 Read SEC document |
| December 31, 2018 Filed Jan 2, 2019 21:19 UTC |
Lagano RoxanneExecutive Vice President
|
Exercise / conversionCommon Stock | 2,000 | $30.89 | $61,780.00 |
DisclosureSEC source: 0001555280-19-000002 · wf-form4_154646395153651.xml · nonDerivative · entry 1 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,023 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018. Read SEC document |
| December 17, 2018 Filed Dec 18, 2018 16:15 UTC |
STEERE WILLIAM C JRDirector
|
GrantPhantom Stock Unit · Derivative | 294.3254 | $84.94 | $25,000.00 |
DisclosureSEC source: 0001555280-18-000282 · wf-form4_154516772586545.xml · derivative · entry 1 STEERE WILLIAM C JR · CIK 0001033870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,600.9867 Underlying: Common Stock · 294.3254 shares Expires not disclosed F1 · security: These phantom stock units were acquired pursuant to the Zoetis Non-Employee Director Deferred Compensation Plan and represent the director's deferral of all or a portion of his or her cash retainer fees invested in the Zoetis stock fund (including dividend equivalents thereon). F2 · derivative.exercise_price: Each phantom stock unit represents one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: These phantom stock units will be settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F3 · derivative.expiration_date: These phantom stock units will be settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| December 17, 2018 Filed Dec 18, 2018 21:18 UTC |
PARENT LOUISE MDirector
|
GrantPhantom Stock Unit · Derivative | 294.3254 | $84.94 | $25,000.00 |
DisclosureSEC source: 0001555280-18-000283 · wf-form4_154516790513256.xml · derivative · entry 1 PARENT LOUISE M · CIK 0001209456 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,825.6578 Underlying: Common Stock · 294.3254 shares Expires not disclosed F1 · security: These phantom stock units were acquired pursuant to the Zoetis Non-Employee Director Deferred Compensation Plan and represent the director's deferral of all or a portion of his or her cash retainer fees invested in the Zoetis stock fund (including dividend equivalents thereon). F2 · derivative.exercise_price: Each phantom stock unit represents one share of Zoetis Inc. common stock. F3 · derivative.exercise_date: These phantom stock units will be settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F3 · derivative.expiration_date: These phantom stock units will be settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| December 03, 2018 Filed Dec 6, 2018 22:20 UTC |
Chen Heidi C.Executive Vice President
|
OtherPhantom Stock Unit · Derivative | 15,760.9865 | $29.50 | $464,949.10 |
DisclosureSEC source: 0001555280-18-000277 · wf-form4_154413480498177.xml · derivative · entry 3 Chen Heidi C. · CIK 0001567828 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,968.9976 shares Expires not disclosed F3 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F4 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F3 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F3 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| December 03, 2018 Filed Dec 6, 2018 22:20 UTC |
Chen Heidi C.Executive Vice President
|
OtherCommon Stock | 2,534.468 | $93.57 | $237,150.17 |
DisclosureSEC source: 0001555280-18-000277 · wf-form4_154413480498177.xml · nonDerivative · entry 2 Chen Heidi C. · CIK 0001567828 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By 401(k) Plan Disclosed balance after: 0 F2 · security: Represents common stock equivalents held in the Zoetis Inc. Savings Plan, a 401(k) plan. F2 · balance_after: Represents common stock equivalents held in the Zoetis Inc. Savings Plan, a 401(k) plan. Read SEC document |
| December 03, 2018 Filed Dec 6, 2018 22:20 UTC |
Chen Heidi C.Executive Vice President
|
SaleCommon Stock | 2,500 | $93.51 | $233,775.00 |
DisclosureSEC source: 0001555280-18-000277 · wf-form4_154413480498177.xml · nonDerivative · entry 1 Chen Heidi C. · CIK 0001567828 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,662 F1 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.51 to $93.53, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 30, 2018 Filed Dec 3, 2018 16:17 UTC |
Reed Willie MDirector
|
SaleCommon Stock | 3,205 | $93.74 | $300,436.70 |
DisclosureSEC source: 0001555280-18-000275 · wf-form4_154387184520751.xml · nonDerivative · entry 1 Reed Willie M · CIK 0001601695 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 566 F1 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.73 to $93.80, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 12, 2018 Filed Nov 13, 2018 21:16 UTC |
PECK KRISTIN CExecutive Vice President
|
Exercise / conversionStock Option · Derivative | 7,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-18-000273 · wf-form4_154214377349800.xml · derivative · entry 3 PECK KRISTIN C · CIK 0001488267 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 253,658 Underlying: Common Stock · 7,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. Each option vests on the third anniversary of the date of grant. F3 · derivative.exercise_price: 7,500 options granted January 31, 2013 at an exercise price of $26.00 per option. F4 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F5 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F6 · balance_after: 40,385 options granted January 31, 2013 at an exercise price of $26.00 per option; 78,651 options granted March 4, 2014 at an exercise price of $30.89 per option; 37,132 options granted February 27, 2015 at an exercise price of $46.09 per option; 40,214 options granted February 19, 2016 at an exercise price of $41.83 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; and 24,642 options granted February 13, 2018 at an exercise price of $73.24 per option. Read SEC document |
| November 12, 2018 Filed Nov 13, 2018 21:16 UTC |
PECK KRISTIN CExecutive Vice President
|
SaleCommon Stock | 11,500 | $94.78 | $1,089,970.00 |
DisclosureSEC source: 0001555280-18-000273 · wf-form4_154214377349800.xml · nonDerivative · entry 2 PECK KRISTIN C · CIK 0001488267 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,652 F1 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.24 to $95.18, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 12, 2018 Filed Nov 13, 2018 21:16 UTC |
PECK KRISTIN CExecutive Vice President
|
Exercise / conversionCommon Stock | 7,500 | $26.00 | $195,000.00 |
DisclosureSEC source: 0001555280-18-000273 · wf-form4_154214377349800.xml · nonDerivative · entry 1 PECK KRISTIN C · CIK 0001488267 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,152 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 08, 2018 Filed Nov 9, 2018 21:22 UTC |
Alaix Juan RamonDirector · Chief Executive Officer
|
Exercise / conversionStock Option · Derivative | 150,306 | $0.00 | $0.00 |
DisclosureSEC source: 0001555280-18-000271 · wf-form4_154179854214205.xml · derivative · entry 3 Alaix Juan Ramon · CIK 0001567824 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 962,963 Underlying: Common Stock · 150,306 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant. F3 · derivative.exercise_price: 150,306 options granted January 31, 2013 at an exercise price of $26.00 per option. F4 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant. F5 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant. F6 · balance_after: 312,109 options granted March 4, 2014 at an exercise price of $30.89 per option; 159,954 options granted February 27, 2015 at an exercise price of $46.09 per option; 187,667 options granted February 19, 2016 at an exercise price of $41.83 per option; 170,163 options granted February 14, 2017 at an exercise price of $55.02 per option; and 133,070 options granted February 13, 2018 at an exercise price of $73.24 per option. Read SEC document |
| November 08, 2018 Filed Nov 9, 2018 21:22 UTC |
Alaix Juan RamonDirector · Chief Executive Officer
|
SaleCommon Stock | 150,306 | $94.96 | $14,273,057.76 |
DisclosureSEC source: 0001555280-18-000271 · wf-form4_154179854214205.xml · nonDerivative · entry 2 Alaix Juan Ramon · CIK 0001567824 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,013 F1 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.54 to $95.77, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 08, 2018 Filed Nov 9, 2018 21:22 UTC |
Alaix Juan RamonDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 150,306 | $26.00 | $3,907,956.00 |
DisclosureSEC source: 0001555280-18-000271 · wf-form4_154179854214205.xml · nonDerivative · entry 1 Alaix Juan Ramon · CIK 0001567824 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,319 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 12, 2018 Filed Oct 16, 2018 20:56 UTC |
PECK KRISTIN CExecutive Vice President
|
GrantPhantom Stock Unit · Derivative | 277.6642 | $28.05 | $7,788.48 |
DisclosureSEC source: 0001555280-18-000264 · wf-form4_153972340221515.xml · derivative · entry 1 PECK KRISTIN C · CIK 0001488267 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,757.1317 Underlying: Common Stock · 87.6094 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| October 12, 2018 Filed Oct 16, 2018 16:52 UTC |
Fenton AndrewExecutive Vice President
|
GrantPhantom Stock Unit · Derivative | 204.6481 | $28.05 | $5,740.38 |
DisclosureSEC source: 0001555280-18-000262 · wf-form4_153972313113686.xml · derivative · entry 1 Fenton Andrew · CIK 0001538226 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,096.8411 Underlying: Common Stock · 64.5712 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
| October 12, 2018 Filed Oct 16, 2018 20:54 UTC |
Lagano RoxanneExecutive Vice President
|
GrantPhantom Stock Unit · Derivative | 203.6193 | $28.05 | $5,711.52 |
DisclosureSEC source: 0001555280-18-000263 · wf-form4_153972326500676.xml · derivative · entry 1 Lagano Roxanne · CIK 0001567878 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,329.5147 Underlying: Common Stock · 64.2466 shares Expires not disclosed F1 · security: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F2 · derivative.exercise_price: Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. F1 · derivative.exercise_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. F1 · derivative.expiration_date: These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.